ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug…
ROME TherapeuticsGVNimbus DiscoveryAileron TherapeuticsAtlas VentureCedilla TherapeuticsUERJTufts University
Benjamin Greenbaum
Founder at ROME Therapeutics
ROME TherapeuticsIcahn School of Medicine at Mount Sinai
David Ting
CTO at Zenni Optical
PanTher TherapeuticsROME TherapeuticsTellBioHarvard Medical SchoolMGH Center for Innovation in Digital HealthCare (CIDH)Harvard Medical School and Massachusetts General HospitalHarvard Medical SchoolMassachusetts Institute of Technology (MIT)Duke University School of MedicineDuke University
Jay Parrish
CEO at Pretzel Therapeutics
Arch Venture PartnersInterline TherapeuticsPretzel TherapeuticsROME TherapeuticsLilac TherapeuticsOrbital TherapeuticsChamberlain Senior High SchoolHaas School of BusinessUniversity of California BerkeleyUniversity of South Florida